A detailed history of Jump Financial, LLC transactions in Novavax Inc stock. As of the latest transaction made, Jump Financial, LLC holds 598,018 shares of NVAX stock, worth $5.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
598,018
Holding current value
$5.2 Million
% of portfolio
0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.71 - $17.11 $6.4 Million - $10.2 Million
598,018 New
598,018 $7.55 Million
Q3 2023

Oct 21, 2024

BUY
$6.81 - $9.74 $417,275 - $596,808
61,274 Added 25.4%
302,473 $2.19 Million
Q3 2023

Nov 07, 2023

BUY
$6.81 - $9.74 $417,275 - $596,808
61,274 Added 25.4%
302,473 $2.19 Million
Q2 2023

Oct 21, 2024

SELL
$6.67 - $9.52 $1.13 Million - $1.62 Million
-169,715 Reduced 41.3%
241,199 $1.79 Million
Q2 2023

Aug 07, 2023

SELL
$6.67 - $9.52 $1.13 Million - $1.62 Million
-169,715 Reduced 41.3%
241,199 $1.79 Million
Q1 2023

Oct 21, 2024

BUY
$5.76 - $12.48 $2.37 Million - $5.13 Million
410,914 New
410,914 $2.85 Million
Q1 2023

May 03, 2023

BUY
$5.76 - $12.48 $2.37 Million - $5.13 Million
410,914 New
410,914 $2.85 Million
Q2 2022

Aug 09, 2022

BUY
$36.28 - $75.29 $2.73 Million - $5.67 Million
75,356 New
75,356 $3.88 Million
Q1 2022

May 12, 2022

SELL
$69.73 - $142.9 $118,541 - $242,930
-1,700 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$134.56 - $217.97 $228,752 - $370,549
1,700 New
1,700 $243,000
Q4 2020

Feb 12, 2021

SELL
$78.74 - $139.5 $816,691 - $1.45 Million
-10,372 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $823,951 - $1.85 Million
10,372 New
10,372 $1.12 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.